Evidence map›Paper›PMID 42420847›Full record

ArticleBMC cardiovascular disorders2026

Editorial: introducing special collection on cancer and cardiovascular disorders.

Moez Karim Aziz

Abstract readEditorial
In one paragraph

Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Moez Karim AzizDepartment of Cardiology, Houston Methodist Debakey Heart & Vascular Center, Houston Methodist Hospital, Houston, United States. maziz@houstonmethodist.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This editorial introduces a special collection on cancer and cardiovascular disorders. Over the past 25 years, the link between cancer and cardiovascular disease has been increasingly acknowledged. As such, we present a special collection of articles offering novel insights into how cancer pathogenesis and therapy can lead to cardiovascular morbidity. Ultimately, the cases in this collection underscore the value of an interdisciplinary team when caring for patients with complex cardio-oncologic pathology and the importance of frequent follow up in the clinical setting.

Indexed as

Antineoplastic AgentsCardiovascular DiseasesNeoplasmsHeart Disease Risk FactorsHumansPrognosisAntineoplastic Agents

Identifiers

PMID42420847
PMCPMC13343687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.